Literature DB >> 22476050

Myoid angioendothelioma of the spleen mimicking metastatic disease in a patient with rectal cancer: a radiologic-pathologic correlation.

Kyu Yun Jang1, Myoung Ja Chung, Woo Sung Moon, Myung Hee Sohn, Seung Bae Hwang, Min Ro Lee, Ho Lee, Ho Sung Park.   

Abstract

Myoid angioendothelioma of the spleen is an uncommon, benign vascular tumor that is morphologically characterized by a composite of vascular spaces and stromal cells with myoid feature. Herein, we report a case of the myoid angioendothelioma of the spleen, concurrent with rectal adenocarcinoma. A 41-year-old woman presented with hematochezia for several weeks. Grossly, the rectal mass was a 2.5 × 2-cm ulcerative fungating lesion. The splenic mass was a 2.2 × 2-cm well-circumscribed lesion. Microscopically, the rectal mass was a well-differentiated adenocarcinoma that invaded into the pericolic adipose tissue. The splenic mass was composed of slit-like vascular spaces and fascicles of elongated stromal cells. Vascular endothelial cells were immunopositive for CD31, factor VIII-related antigen, and CD34 but negative for CD8. Stromal cells were immunopositive for smooth muscle actin but negative for desmin.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22476050     DOI: 10.1016/j.anndiagpath.2012.03.001

Source DB:  PubMed          Journal:  Ann Diagn Pathol        ISSN: 1092-9134            Impact factor:   2.090


  3 in total

1.  Splenic myoid angioendothelioma mimicking metastatic disease in an 8-year-old with Stage IV Wilms' tumour.

Authors:  Adil A Shah; Dragos C Luca; Timothy D Kane; Mikael Petrosyan
Journal:  BMJ Case Rep       Date:  2018-05-18

2.  Myoid Angioendothelioma of the Spleen: A Rare Case Report and Literature Review.

Authors:  Bita Geramizadeh; Mohammadhossein Anbardar; Seyed-Ali Malekhosseini
Journal:  Iran J Med Sci       Date:  2017-01

3.  Myoid Angioendothelioma: A Rare Benign Splenic Tumor.

Authors:  Vladimir Milosavljevic; Boris Tadic; Mauricio Gonzalez-Urquijo; Djordje Knezevic; Nikola Grubor
Journal:  Balkan Med J       Date:  2021-05       Impact factor: 2.021

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.